Similarly, Entinostat could induce apoptosis in TRAIL-resistant melanoma following combination therapy with TRAIL by up-regulating DR4, DR5, and procaspase 8 expressions, and concurrently c-FLIP downregulating in tumor cells. The gene discussed is CFLAR; the disease is melanoma.